Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer

Overview of attention for article published in Journal of Molecular Biology, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Readers on

mendeley: 107 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

Combination of checkpoint inhibitors and oncolytic viruses to treat cancer

Application KR-20240149434-A

Republic of Korea

14 Oct 2024

COMBINATIONS OF CHECKPOINT INHIBITORS AND ONCOLYTIC VIRUS FOR TREATING CANCER

Application WO-2023159102-A1

World Intellectual Property Organisation (WIPO)

24 Aug 2023

THERAPEUTIC RNA FOR TREATING CANCER

Application WO-2022136266-A1

World Intellectual Property Organisation (WIPO)

30 Jun 2022

BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE

Application WO-2020127377-A1

World Intellectual Property Organisation (WIPO)

25 Jun 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.